Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621022 · ClinicalTrials.gov registry record · Phase 4
Bupropion Alone or Combined With Nicotine Gum
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 608
- Enrollment target
NCT01621022: Completed Phase 4 study, sponsored by University of Wisconsin, Madison.
NCT01621022 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 608 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (17% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01621022, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 608 participants
- Enrollment target
Study Summary
Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.
Primary Outcome
No smoking, not evan a puff, during the 7 days prior to the 6 month follow-up
Interventions
- DRUG bupropion + nicotine gum
- DRUG Active bupropion-Placebo gum
- DRUG Placebo bupropion-Placebo gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2001-01 |
| Est. Completion | 2002-10 |
| Phase | Phase 4 |
What the finished NCT01621022 record still lists
NCT01621022 is an interventional study that assigns participants to a tested intervention. The registered 608 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (17% higher).
The record links to 0 conditions, and to 3 interventions - of which bupropion + nicotine gum is the first listed.
NCT01621022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01621022 about?
NCT01621022 is a clinical study titled "Bupropion Alone or Combined With Nicotine Gum". Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.
What is the current status of trial NCT01621022?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 608 participants. The study started on 2001-01. Estimated completion is 2002-10.
What interventions are being tested in trial NCT01621022?
The interventions under investigation include: bupropion + nicotine gum (DRUG), Active bupropion-Placebo gum (DRUG), Placebo bupropion-Placebo gum (DRUG).
Who is sponsoring clinical trial NCT01621022?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01621022's enrollment target sits among peer trials
608 135th of 2000 higher than 1,865 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
- NCT00823654 · 609 participants
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia